Altered expression patterns of clock gene mRNAs and clock proteins in human skin tumors

Tumor Biology

Volumn 34, Issue 2, 2013, Pages 811-819

  Lengyel, Zsuzsanna ^a   Lovig, Csenge ^a   Kommedal, Siri ^a   Keszthelyi, Rita ^b   Szekeres, György ^b   Battyáni, Zita ^a   Csernus, Valér ^a   Nagy, András Dávid ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Histopathology Ltd   (Hungary)

Author keywords

Circadian rhythm; Clock genes; Human skin cancer; Melanoma; Naevus

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR CLOCK; CIRCADIAN RHYTHM SIGNALING PROTEIN; CLOCK PROTEIN, HUMAN; CRY1 PROTEIN, HUMAN; CRYPTOCHROME; PER1 PROTEIN, HUMAN; PER2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER TISSUE; CELL METABOLISM; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLOCK GENE; CONTROLLED STUDY; CRY1 GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT LENTIGO; MALIGNANT TRANSFORMATION; MELANOMA; MELANOMA CELL; NEVUS; PER1 GENE; PER2 GENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; SKIN CARCINOGENESIS; UPREGULATION; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; GENETICS; MALE; MELANOCYTE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SKIN TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CLOCK PROTEINS; CRYPTOCHROMES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MELANOCYTES; MELANOMA; MIDDLE AGED; PERIOD CIRCADIAN PROTEINS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

MLCS; MLOWN;

EID: 84877135327     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0611-0     Document Type: Article

References (35)

1. Sancar A, Lindsey-Boltz LA, Kang TH, Reardon JT, Lee JH, Ozturk N. Circadian clock control of the cellular response to DNA damage. FEBS Letters. 2010;584:2618-25.
2. Sahar S, Sassone-Corsi P. Metabolism and cancer: the circadian clock connection. Nature Reviews Cancer. 2009;9:886-96.
3. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. Journal of the National Cancer Institute. 2001;93:1557-62.
4. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. Journal of the National Cancer Institute. 2001;93:1563-8.
5. Schernhammer ES, Laden F, Speizer FE, et al. Night-shift work and risk of colorectal cancer in the nurses' health study. Journal of the National Cancer Institute. 2003;95:825-8.
6. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. The Lancet Oncology. 2007;8:1065-6.
7. Hastings M, O'Neill JS, Maywood ES. Circadian clocks: regulators of endocrine and metabolic rhythms. Journal of Endocrinology. 2007;195:187-98.
8. Tanioka M, Yamada H, Doi M, et al. Molecular clocks in mouse skin. The Journal of Investigative Dermatology. 2009;129:1225-31.
9. Antoch MP, Kondratov RV, Takahashi JS. Circadian clock genes as modulators of sensitivity to genotoxic stress. Cell Cycle. 2005;4:901-7.
10. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Molecular Cell. 2006;22:375-82.
11. Granda TG, Liu XH, Smaaland R, et al. Circadian regulation of cell cycle and apoptosis proteins in mouse bone marrow and tumor. The FASEB Journal. 2005;19:304-6.
12. Gréchez-Cassiau A, Rayet B, Guillaumond F, Teboul M, Delaunay F. The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. Journal of Biological Chemistry. 2008;283:4535-42.
13. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003;302:255-9.
14. van den Heiligenberg S, Deprés-Brummer P, Barbason H, Claustrat B, Reynes M, Lévi F. The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats. Life Sciences. 1999;64:2523-34.
15. Spörl F, Schellenberg K, Blatt T, et al. A circadian clock in HaCaT keratinocytes. J Innvest Dermatol. 2011;131(2):338-48.
16. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002;111:41-50.
17. Antoch MP, Gorbacheva VY, Vykhovanets O, et al. Disruption of the circadian clock due to the clock mutation has discrete effects on aging and carcinogenesis. Cell Cycle. 2008;7:1197-204.
18. Ozturk N, Lee JH, Gaddameedhi S, Sancar A. Loss of cryptochrome reduces cancer risk in p53 mutant mice. Proc Natl Acad Sci USA. 2009;106:2841-6.
19. Cao Q, Gery S, Dashti A, et al. A role for the clock gene PER1 in prostate cancer. Cancer Research. 2001;69:7619-25.
20. Gery S, Komatsu N, Kawamata N, et al. Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer. Clinical Cancer Research. 2007;13:1399-404.
21. Hsu CM, Lin SF, Lu CT, Lin PM, Yang MY. Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biology. 2012;33:149-55.
22. Lin YM, Chang JH, Yeh KT, et al. Disturbance of circadian gene expression in hepatocellular carcinoma. Molecular Carcinogenesis. 2008;47:925-33.
23. Shih MC, Yeh KT, Tang KP, Chen JC, Chang JG. Promoter methylation in circadian genes of endometrial cancers. Molecular Carcinogenesis. 2006;45:732-40.
24. Yeh KT, Yang MY, Liu TC, et al. Abnormal expression of period I (PERI) in endometrial carcinoma. The Journal of Pathology. 2005;206:111-20.
25. Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia. 2007;9:797-800.
26. Doi M, Hirayama J, Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell. 2006;125:497-508.
27. Alhopuro P, Björklund M, Sammalkorpi H, et al. Mutations in the circadian gene CLOCK in colorectal cancer. Molecular Cancer Research. 2010;8:952-60.
28. Soták M, Polidarová L, Ergang P, Sumová A, Pácha J. An association between clock genes and clock-controlled cell cycle genes in murine colorectal tumors. International Journal of Cancer. 2012. doi: 10.1002/ijc.27760.
29. Bjarnason GA, Jordan RC, Wood PA, et al. Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. American Journal of Pathology. 2001;158:1793-801.
30. Zanello SB, Jackson DM, Holick MF. Expression of the circadian clock genes clock and period 1 in human skin. J Invest Dermato l. 2000;115:757-60.
31. Sandu C, Dumas M, Malan A, et al. Human skin keratinocytes, melanocytes, and fibroblasts contain distinct circadian clock machineries. Cellular and Molecular Life Sciences. 2012. doi: 10.1007/s0001801210261.
32. Geyfman M, Andersen B. Clock genes, hair growth and aging. Aging (Albany NY). 2010;2:122-8.
33. Gaddameedhia S, Selbya CP, Kaufmann WK, Smarte RC, Sancar A. Control of skin cancer by the circadian rhythm. Proceedings of the National Academy of Sciences of the United States of America. 2011;108:18790-5.
34. Kovach B, Langland R, Schilling R, et al. The analytic performance of the cobasR 4800 BRAF V600 mutation test in the detection of V600E mutations in malignant melanoma: assay reproducibility and effects of melanin. Melanoma Research. 2011;21:e11.
35. de Kok JB, Roelofs RW, Giesendorf BA, et al. Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Laboratory Investigation. 2005;85:154-9.